JP7614105B2 - 外傷後免疫抑制の治療又は予防への使用のための藻類抽出物 - Google Patents

外傷後免疫抑制の治療又は予防への使用のための藻類抽出物 Download PDF

Info

Publication number
JP7614105B2
JP7614105B2 JP2021546474A JP2021546474A JP7614105B2 JP 7614105 B2 JP7614105 B2 JP 7614105B2 JP 2021546474 A JP2021546474 A JP 2021546474A JP 2021546474 A JP2021546474 A JP 2021546474A JP 7614105 B2 JP7614105 B2 JP 7614105B2
Authority
JP
Japan
Prior art keywords
ulva
extract
cells
mice
sulfated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021546474A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508900A5 (https=
JP2022508900A (ja
Inventor
アセヌーネ カリム
ジャクリーヌ セドリック
ブラ マルワーン
ロキリー アントワーヌ
ニバル－コレン ピ
ドゥメ エルベ
バリュッソン エルベ
Original Assignee
アマデテ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アマデテ filed Critical アマデテ
Publication of JP2022508900A publication Critical patent/JP2022508900A/ja
Publication of JP2022508900A5 publication Critical patent/JP2022508900A5/ja
Application granted granted Critical
Publication of JP7614105B2 publication Critical patent/JP7614105B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2021546474A 2018-10-22 2019-10-22 外傷後免疫抑制の治療又は予防への使用のための藻類抽出物 Active JP7614105B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
FR1859721 2018-10-22
PCT/EP2019/078757 WO2020083931A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Publications (3)

Publication Number Publication Date
JP2022508900A JP2022508900A (ja) 2022-01-19
JP2022508900A5 JP2022508900A5 (https=) 2024-03-05
JP7614105B2 true JP7614105B2 (ja) 2025-01-15

Family

ID=65494363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546474A Active JP7614105B2 (ja) 2018-10-22 2019-10-22 外傷後免疫抑制の治療又は予防への使用のための藻類抽出物

Country Status (10)

Country Link
US (1) US12377126B2 (https=)
EP (2) EP3870198B1 (https=)
JP (1) JP7614105B2 (https=)
KR (1) KR102922546B1 (https=)
CN (1) CN113347984A (https=)
AU (2) AU2019364677B2 (https=)
CA (1) CA3116952A1 (https=)
FR (1) FR3087338B1 (https=)
IL (1) IL282511B1 (https=)
WO (1) WO2020083931A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114376233A (zh) * 2022-03-23 2022-04-22 青岛海大生物集团股份有限公司 一种具有增强免疫功能的浒苔多糖保健食品及制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526500A (ja) 2002-02-27 2005-09-08 ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト グラム陰性細菌感染に対する免疫応答を引き出す組成物及び方法
JP2007525426A (ja) 2003-04-08 2007-09-06 バイオテンプト、ビー．ヴイ． Ｈｃｇ断片を含む粘膜及び経口投与のための組成物優先権本出願は、２００３年４月８日に欧州特許庁（ｅｐｏ）に出願したｅｐ０３０７６０２８．４、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２９．２、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２７．６、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２６．８、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２２．７、ｕｓ１０／４０９，６７１、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２１．９、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２５．０、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２４．３、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０３０．０、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２３．５、２００３年４月３０日に中国特許庁に出願したｃｎ０３１３１２２７．６の優先権を主張する。
JP2008546808A (ja) 2005-06-24 2008-12-25 デザート レイク テクノロジーズ 藍藻類の精製成分および使用方法
JP2010538282A (ja) 2007-09-07 2010-12-09 ウニヴェルズィテート・ツューリヒ ヒト敗血症を測定する方法
US20130028936A1 (en) 2009-12-28 2013-01-31 Universite De Nantes Tlr 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries
US20130102662A1 (en) 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
JP2016539184A (ja) 2013-11-18 2016-12-15 アマデイト 免疫調節剤としての用いるための藻類抽出物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102829B1 (ko) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 구멍갈파래 추출물과 그것의 항염증제로서의 용도
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
FR2999084B1 (fr) * 2012-12-11 2015-03-13 Amadeite Extrait d'algues comprenant en particulier des polysaccharides polyanioniques sulfates et non sulfates et ses applications
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526500A (ja) 2002-02-27 2005-09-08 ドゥーケーン ユニバーシティ オブ ザ ホーリー ゴースト グラム陰性細菌感染に対する免疫応答を引き出す組成物及び方法
JP2007525426A (ja) 2003-04-08 2007-09-06 バイオテンプト、ビー．ヴイ． Ｈｃｇ断片を含む粘膜及び経口投与のための組成物優先権本出願は、２００３年４月８日に欧州特許庁（ｅｐｏ）に出願したｅｐ０３０７６０２８．４、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２９．２、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２７．６、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２６．８、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２２．７、ｕｓ１０／４０９，６７１、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２１．９、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２５．０、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２４．３、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０３０．０、２００３年４月８日にｅｐｏに出願したｅｐ０３０７６０２３．５、２００３年４月３０日に中国特許庁に出願したｃｎ０３１３１２２７．６の優先権を主張する。
JP2008546808A (ja) 2005-06-24 2008-12-25 デザート レイク テクノロジーズ 藍藻類の精製成分および使用方法
JP2010538282A (ja) 2007-09-07 2010-12-09 ウニヴェルズィテート・ツューリヒ ヒト敗血症を測定する方法
US20130028936A1 (en) 2009-12-28 2013-01-31 Universite De Nantes Tlr 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries
US20130102662A1 (en) 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
JP2016539184A (ja) 2013-11-18 2016-12-15 アマデイト 免疫調節剤としての用いるための藻類抽出物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Algal Research，2017年，28，pp. 39-47
International Journal of Biological Macromolecules，2016年，Vol.92 ，pp.820-830
機能性食品と薬理栄養，2018年12月01日，Vol.12, No.3，Page.182

Also Published As

Publication number Publication date
US20210386808A1 (en) 2021-12-16
US12377126B2 (en) 2025-08-05
AU2019364677A1 (en) 2021-05-20
KR102922546B1 (ko) 2026-02-04
AU2025200105A1 (en) 2025-01-23
BR112021007506A2 (pt) 2021-07-27
IL282511A (en) 2021-06-30
JP2022508900A (ja) 2022-01-19
WO2020083931A1 (fr) 2020-04-30
EP4483961A3 (fr) 2025-03-19
EP4483961A2 (fr) 2025-01-01
FR3087338B1 (fr) 2020-10-09
EP3870198C0 (fr) 2024-11-20
EP3870198A1 (fr) 2021-09-01
KR20210114921A (ko) 2021-09-24
IL282511B1 (en) 2026-02-01
EP3870198B1 (fr) 2024-11-20
CA3116952A1 (fr) 2020-04-30
FR3087338A1 (fr) 2020-04-24
AU2019364677B2 (en) 2024-10-10
CN113347984A (zh) 2021-09-03

Similar Documents

Publication Publication Date Title
KR101826071B1 (ko) 포유동물 체내에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
US8404250B2 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
AU2025200105A1 (en) Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
JP4160532B2 (ja) 免疫を増強するための医薬組成物、およびポリア抽出物
JP2022508900A5 (https=)
BR112021007506B1 (pt) Uso de um extrato de algas verdes do tipo ulva
US8105601B2 (en) Compositions and methods for modulating an immune response
Santosa et al. THE EFFECT OF MORINGA LAM LEAF EXTRACT ON PHAGOCYTOSIS ACTIVITY OF MACROPHAGES, ROS, NO, IFN-γ, AND IL-10 ON PBMC IN ADULT PULMONARY TUBERCULOSIS PATIENTS INDUCED BY ESAT-6 IN-VITRO
CN118161534A (zh) 弗格森埃希菌及其产品在炎症疾病中的用途
KR101828044B1 (ko) 수지상 세포 및 항생제를 포함하는 결핵 예방 또는 치료용 조성물
HK1067073B (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
CN103690566A (zh) 眼镜蛇蛇毒在制备免疫调节剂中的应用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230822

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231121

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20240222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240514

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240813

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240912

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241226

R150 Certificate of patent or registration of utility model

Ref document number: 7614105

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150